An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic delivery
Ni‐Chung Lee(National Taiwan University Hospital), Wuh‐Liang Hwu(MRC Epidemiology Unit), Rachael Watson(University of Florida), Thomas J. Conlon(Adelson Foundation), Hung‐Chuan Chiu(Institute of Molecular Biology, Academia Sinica), Darin J. Falk, Marda Jorgensen(University of Florida), Mark Potter(University of Florida), Kirsten Erger(University of Florida), Stacy Porvasnik(University of Florida), Barry J. Byrne(University of Florida), Nathalie Clément(University of Florida), Steven C. Ghivizzani(University of Florida), Yin‐Hsiu Chien(National Taiwan University Hospital)
Cited by 5
Related Papers
Treatment of Leber Congenital Amaurosis Due to <i>RPE65</i> Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
|Human Gene Therapy|2008|950
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Biparental Inheritance of Mitochondrial DNA in Humans
|Proceedings of the National Academy of Sciences|2018|451
PSORS2 Is Due to Mutations in CARD14
|The American Journal of Human Genetics|2012|414
Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
|Circulation Research|2006|400